Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: May 7, 2002
Last updated: February 23, 2015
Last verified: January 2015